Effect of Huanglian Wendantang in Treatment of Metabolic Syndrome
10.13422/j.cnki.syfjx.20201721
- VernacularTitle:黄连温胆汤治疗代谢综合征研究进展
- Author:
Li LIU
1
;
Wei-zhong LI
2
;
Guo-liang ZOU
1
;
Yan-bo SUI
1
;
Juan JIN
1
;
Xiao-xue WANG
2
;
Fan WU
2
;
Yu-bo HAN
1
Author Information
1. First Affiliated Hospital,Heilongjiang University of Chinese Medicine,Harbin 150040,China
2. Heilongjiang University of Chinese Medicine,Harbin 150040,China
- Publication Type:Research Article
- Keywords:
Huanglian Wendantang;
metabolic syndrome;
insulin resistance;
inflammatory response;
oxidative stress;
study progress
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(17):190-196
- CountryChina
- Language:Chinese
-
Abstract:
Metabolic syndrome (MS) is a pathological condition characterized by central obesity, insulin resistance, hypertension, and hyperlipidemia. With the increase of poor dietary habits and lifestyles in modern society, especially the poor living habits of sedentariness and less movement, the prevalence of MS has increased year by year. According to relevant data, the number of MS patients worldwide will reach about 2.568 billion by 2040, which will seriously endanger human life and health. Huanglian Wendantang, as a famous traditional Chinese medicine prescription for clearing away heat and drying dampness, regulating Qi and resolving phlegm, and benefiting the stomach and gall, has been proved to have significant pharmacological effects in lowering blood fat, reducing blood sugar and resisting inflammation by modern pharmacological studies, and widely used in the treatment of metabolic diseases, cardiovascular diseases and other systemic diseases. In recent years, a large number of studies have proved that Huanglian Wendantang has a significant effect on MS. In terms of clinical efficacy, it could significantly improve the pathological state of obesity, dyslipidemia, abnormal glucose metabolism and hypertension in MS patients. Meanwhile, it could also interfere with the inflammatory state, prethrombotic state, abnormal vascular regulation and other potential risk factors in the body, with a high safety and fewer side effects. In terms of experimental study, it could enhance the insulin sensitivity, and improve the insulin resistance of MS animal models and cell models through interventions in insulin signal transduction, inflammatory response, and antioxidant stress. By retrieving PubMed, CNKI, Weipu, Wanfang and other databases, the author summarized the study reports of Huanglian Wendantang on MS in recent years in three aspects: theoretical study, clinical efficacy study and experimental mechanism study, in the expectation of provide some scientific references for in-depth study of the mechanism of Huanglian Wendantang in treating MS and the development and clinical promotion of the prescription.
